1.	Phase I Triazine Triepoxide (Henkel's Compound, NSC-296934) Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: NCI-W82-0241
2.	Phase I and Pharmacologic Study of Triazine Triepoxide (NSC-296934) Administered on Single-Day and on Daily-for-5-Day Schedules Phase: Phase I Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-W81-1034
3.	Phase I Trial of Intraperitoneal Teroxirone in Patients with Metastatic Solid Tumor Largely Confined to the Abdominal Cavity (Summary Last Modified 04/89) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UMCC-8802, NCI-T88-0078C, T88-0078
4.	Phase I Study of Intraperitoneal Teroxirone in Patients with Advanced Malignancies Principally Confined to the Peritoneal Cavity (Summary Last Modified 04/91) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-90166, NCI-T91-0002C, T91-0002